corresp
|
|
|
Ms. Angela Crane
|
|
November 26, 2007 |
Branch Chief |
|
|
Division of Corporation Finance |
|
|
Securities and Exchange Commission |
|
|
Washington, D.C. 20549 |
|
|
USA |
|
|
|
|
|
Re:
|
|
IMAX Corporation (the Company) |
|
|
Response to SEC Comment Letter dated August 17, 2007
|
|
|
File No. 000-24216 |
Dear Ms. Crane:
We would like to again express our appreciation for the time and consideration provided by the
staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission (the
Staff) concerning the matters presented in the Companys letter dated September 26, 2007 and the
revised Exhibit 1 presented to the Staff on October 24, 2007.
During our discussions on November 2, 2007, the Staff noted certain areas presented in Exhibit 1
where it would require clarification or additional information from the Company in order to further
its review. As a result, the Company has provided the following further revised Exhibit 1 (clean
and blacklined to show changes) to its October 24, 2007 response. The revised Exhibit 1, which
is attached, documents such information and should replace Exhibit 1 of the October 24, 2007
submission.
|
|
|
|
|
IMAX CORPORATION |
|
|
2525 Speakman Drive |
|
|
Mississauga, Ontario |
|
|
Canada L5K 1B1 |
|
|
t 905.403.6500 f 905.403.6450 |
|
|
www.imax.com |
**************************************************
Should you require clarification or have any further questions, please contact me at (212)
821-0166. The Company stands ready to assist the Staff in any way possible in connection with the
matters addressed in this letter.
Thank you,
|
|
|
|
|
|
|
|
/s/ Joseph Sparacio
|
|
|
Joseph Sparacio |
|
|
Chief Financial Officer |
|
|
|
|
|
|
cc:
|
|
Kevin Kuhar, Staff Accountant, Division of Corporation Finance, Securities and Exchange Commission |
|
|
Jodie Hancock, Senior Accountant, Corporate Finance Branch, Ontario Securities Commission |
|
|
PricewaterhouseCoopers LLP |
|
|
Robert Lister, IMAX Corporation |
|
|
Members of Audit Committee, IMAX Corporation |
2
Exhibit 1
Pages A-1 to A-10
[Omitted pursuant to a request for confidential treatment and submitted separately with the
Commisssion]
A-1